在转移性割抵抗性前列腺癌患者的旅程中导航治疗序列
Hannah D McManus1, Tanya Dorff2, Alicia K Morgans3
1Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, NC, USA.
Prostate cancer and prostatic diseases
|October 17, 2024
概括
选择转移性割抵抗性前列腺癌 (mCRPC) 的最佳治疗方法需要考虑患者病史,临床因素和利用遗传检测. 像PARP抑制剂和[177Lu]Lu-PSMA-617这样的新疗法提供了更好的结果.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 医学治疗学 医学治疗学
背景情况:
- 转移性割耐药前列腺癌 (mCRPC) 尽管有新型疗法,但在治疗选择方面存在挑战.
- 对mCRPC治疗药物的最佳测序仍然是临床不确定性的领域.
研究的目的:
- 提供对不断变化的mCRPC治疗环境的概述.
- 讨论指南推的选择和mCRPC的临床试验数据.
- 根据个体患者的因素,为最佳治疗顺序提供建议.
主要方法:
- 关于mCRPC的关键临床试验和治疗指南的综合文献综述.
- 识别mCRPC治疗中的知识差距和未来研究方向.
主要成果:
- 对mCRPC的治疗选择取决于患者病史,临床特征,症状,预后和试验可用性.
- 基因检测和PSMA向成像对于评估新药的适用性至关重要.
- 新兴的疗法包括PARP抑制剂,AR途径抑制剂和[177Lu]Lu-PSMA-617.
结论:
- 在mCRPC治疗环境是动态的,正在进行的试验影响未来的策略.
- 以患者特定因素为指导的个性化治疗顺序对于最佳的mCRPC管理至关重要.
- 在临床试验证据的背景下,讨论了指南推的选择和新兴疗法.
更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.0K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K